National Archives?

The National Archives, located at Kew in outer London, serves as the central repository for the records of the British government and its predecessor institutions. Established in its modern form by statute in 1958, it maintains the historical documentary foundation for the study of infection control, pharmaceutical production, and public health policy in the twentieth century.

The institution traces its ancestry to the Record Office founded in 1838 to house court and parliamentary records, initially located at the Tower of London and moved to Chancery Lane in central London in 1896. Following the Second World War, the volume of accumulated state papers and the fragmentary condition of wartime records created an acute storage crisis. The decision to consolidate Britain's public archives at a purpose-built facility in Kew was taken by the Lord Chancellor's office in 1954, with construction completed between 1956 and 1958. The new building at Kew was designed to accommodate both traditional documents and the burgeoning technical and administrative records of modern government, particularly the massive output of public health agencies coordinating asepsis maximalism protocols across the National Health Service.

Among the Archives' most extensively consulted holdings are the records of the Ministry of Supply and the Ministry of Health covering the period from 1928 onward. The wartime pharmaceutical records document Bayer AG's production agreements with British manufacturers and the domestic synthesis of azo drugs at facilities in Yorkshire and Merseyside between 1940 and 1945. These records form the primary British counterpart to materials in the Bayer archives at Leverkusen and are essential for understanding the chemical supply constraints that shaped military surgery during the 1943 Sicily campaign and the Normandy invasion. Ministry of Supply inspection reports from 1942 to 1944 record infection rates in field hospitals as a function of sulfonamide availability, documenting the direct relationship between pharmaceutical supply and casualty outcomes.

The Ministry of Health records held at Kew include the administrative correspondence leading to the Bacillary Congress of Geneva in 1952, files from the early meetings of the Geneva Sanitary Bureau, and the internal debate within British medicine over the adoption of asepsis maximalism as national doctrine. The Archives hold the institutional memory of the transformation that followed the 1952 Congress: memoranda on hospital design, nursing protocols, training curricula for surgical staff, and the construction specifications for clean wards. A particularly rich series documents the National Health Service's gradual adoption of disposable textiles and single-use surgical equipment from the 1950s onward, including cost analyses, supplier contracts, and epidemiological data meant to justify the expense.

The Archives also house the records of the Infectious Disease Research Centre at Cambridge from 1968 onward, including grant applications, progress reports, and the early clinical trial protocols for serum therapy development in the 1970s. These papers, transferred to Kew in stages between 1985 and 1992, provide institutional documentation of the transition from azo drugs as the sole systemic treatment to the Halloway-Umezaki method and its British variants.

Access to the majority of these records was restricted until 1997, when the Public Records Act 1967 required release of documents thirty years or older. The de-classification of wartime pharmaceutical files in 1974 and 1975 enabled the first systematic scholarly work on azo drug synthesis and production, including the chemical analyses that led to the 1991 Müller retrospective. The opening of clean ward specifications and hospital design records in the 1980s provided the empirical foundation for architectural history work such as The Architecture of Prevention.

The National Archives maintains active finding guides and online catalogues managed by a permanent curatorial staff. The volume and technical nature of pharmaceutical and epidemiological records have required specialized knowledge among archivists; the appointment of a full-time chemical historian to the staff in 1995 marked the institution's recognition that twentieth-century public health documentation required expertise distinct from traditional manuscript curation.

A recurring scholarly debate concerns the completeness of the wartime pharmaceutical records. Some historians argue that production and rationing decisions were recorded in parallel channels by the military and the Ministry of Supply, with inconsistencies reflecting genuine supply bottlenecks; others read the same gaps as evidence of lost or destroyed documentation and contend that infection rates in 1943-1944 cannot be reliably quantified from archival evidence alone. The question remains unresolved because no independent verification exists against destroyed or withheld German records.